Abstract:BACKGROUND:Islet transplantation represents an ideal therapeutic approach for treatment of type 1 diabetes but islet function and regeneration may be influenced by necrosis or apoptosis induced by oxidative stress and other insults. Heme oxygenase-1 (HO-1) is the rate-limiting enzyme in the catabolism of heme into biliverdin, releasing free iron and carbon monoxide. It has also been reported to be an antioxidant enzyme which can improve the function of grafted islets by cytoprotection via free radical scavenging and apoptosis prevention. In the present study, we investigated whether transduction of HO-1 genes into human islets with an adenovirus vector has cytoprotective action on islets cultured in vitro and discuss this method of gene therapy for clinical islet transplantation.METHODS:Cadaveric pancreatic islets were isolated and purified in vitro. Transduction efficiency of islets was determined by infecting islets with adenovirus vector containing the enhanced green fluorescent protein gene (Ad-EGFP) at multiplicities of infection (MOI) of 2, 5, 10, or 20. Newly isolated islets were divided into three groups: EGFP group, islets transduced with Ad-EGFP using MOI = 20; HO-1 group, transduced with adenovirus vectors containing the human HO-1 gene using MOI = 20; and control group, mock transduced islets. Insulin release after glucose stimulation of the cell lines was determined by a radioimmunoassay kit and the stimulation index was calculated. Flow cytometry was used to detect apoptotic cells in the HO-1 group and in the control group after induction by recombinant human tumor necrosis factor-alpha (rTNFalpha) and cycloheximide (CHX) for 48 hours.RESULTS:Adenovirus vectors have a high efficiency of gene transduction into adult islet cells. Transduction of islets with the Ad-EGFP was most successful at MOI 20, at which MOI fluorescence was very intense on day 7 after transduction and EGFP was expressed in cultured islet cells for more than four weeks in vitro. The insulin release in the control group was (182.36 +/- 58.96) mIU/L after stimulation by high glucose media (16.7 mmol/L), while insulin release from the HO-1 group and the EGFP group were (270.09 +/- 89.37) mIU/L and (175.95 +/- 75.05) mIU/L respectively. Compared to the control group and the EGFP group, insulin release in the HO-1 group increased significantly (P < 0.05). After treatment with rTNFalpha and CHX the apoptotic ratio of islet cells was (63.09 +/- 10.86)% in the HO-1 group, significantly lower than (90.86 +/- 11.25)% in the control group (P < 0.05).CONCLUSIONS:Transduction of human islets with Ad-HO-1 can protect against TNF-alpha and CHX mediated cytotoxicity. The HO-1 gene also appears to facilitate insulin release from human islets. Transduction of donor islets with the adenovirus vector containing an HO-1 gene might have potential value in clinical islet transplantation.

Protection of Human Islets from Induction of Apoptosis and Improved Islet Function with HO-1 Gene Transduction

Transduction of Heme Oxygenase-1 Gene to Human Islet Cells Via Adenovirus Vector Enhances Anti- Apoptosis Function and Insulin Release

Transplantation of rat islets transduced with human heme oxygenase-1 gene using adenovirus vector.

Protection of Rat Islet Viability Following Heme Oxygenase-1 Gene Transfection Via Adenoviral Vector in Vitro

Effect of Heme oxygenase-1 gene transfection on cultured rat pancreatic islets

Hemo Oxygenase-1 Induction in Vitro and in Vivo Can Yield Pancreas Islet Xenograft Survival and Improve Islet Function

[Protective Effect of Cotransfection of A20 and HO-1 Gene Against the Apoptosis Induced by TNF-α in Rat Islets in Vitro].

The Protective Effect of Heme-Oxygenase-1 in Isolated Islets Xenotransplantation

The Protection of Xenotransplanted Murine Pancreatic Islets by Induced Expression of Heme Oxygenase-1

The Introduction of Human Heme Oxygenase-1 and Soluble Tumor Necrosis Factor-α Receptor Type I With Human IgG1 Fc in Porcine Islets Prolongs Islet Xenograft Survival in Humanized Mice

Effect of human HO-1 gene transfection with adenovirus vector on pancreatic islet allografts

315.5: Overexpression of CTRP9 Mediated by AAV Prevents Graft Loss after Islet Transplantation

Adenoviral Transfection of Isolated Pancreatic Islets: A Study of Programmed Cell Death (Apoptosis) and Islet Function

Cytoprotective effects of human interleukin-10 gene transfer against necrosis and apoptosis induced by hepatic cold ischemia/reperfusion injury.

Protective Effect of Heme Oxygenase-1 to Pancreas Islet Xenograft

Adiponectin Gene Therapy Prevents Islet Loss after Transplantation

Overexpression of Suppressor of Cytokine Signaling 1 in Islet Grafts Results in Anti-Apoptotic Effects and Prolongs Graft Survival.

Insulin gene transfer enhances the function of human islet grafts

Recombinant Adenovirus Vector Ad-hIL-10 Protects Grafts from Cold Ischemia-Reperfusion Injury Following Orthotopic Liver Transplantation in Rats.

Generation and characterization of human heme oxygenase-1 transgenic pigs

Protective effect of cobalt protoporphyrin-induced the strong expression of heme oxygenase-1 on islet xenotransplant